ym 872 has been researched along with perampanel in 1 studies
| Studies (ym 872) | Trials (ym 872) | Recent Studies (post-2010) (ym 872) | Studies (perampanel) | Trials (perampanel) | Recent Studies (post-2010) (perampanel) |
|---|---|---|---|---|---|
| 41 | 0 | 5 | 520 | 75 | 508 |
| Protein | Taxonomy | ym 872 (IC50) | perampanel (IC50) |
|---|---|---|---|
| Glutamate receptor 1 | Homo sapiens (human) | 1.8082 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carcache, D; Kalkman, HO; Koller, M; Mattes, H | 1 |
1 other study(ies) available for ym 872 and perampanel
| Article | Year |
|---|---|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
Topics: Analgesics; Animals; Anticonvulsants; Antipsychotic Agents; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Neuroprotective Agents; Protein Subunits; Receptors, AMPA | 2010 |